{
    "nctId": "NCT02729701",
    "briefTitle": "Pilot Study of the Effect of Duavee\u00ae on Benign Breast Tissue Proliferation",
    "officialTitle": "Pilot Study of the Effect of Duavee\u00ae on Benign Breast Tissue Proliferation in Peri or Post-menopausal Women at Moderate Risk for Development of Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 28,
    "primaryOutcomeMeasure": "Feasibility for a Larger Trial",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with vasomotor symptoms with a uterus who are postmenopausal or in late menopause transition\n* Body Mass Index (BMI) \\<36 kg/m2\n* Class I-III mammogram within 6 months of Random Periareolar Fine Needle Aspiration (RPFNA); If Class 0 or 4, must be resolved with additional procedures\n* If previously on oral contraceptives or hormone replacement, off for 8 weeks or more prior to baseline RPFNA; the exception is low dose vaginal hormones\n* Confirmed moderate risk of developing breast cancer\n* RPFNA results within study defined range\n* Kidney and liver function within study defined range\n* Willing and able to comply with study related procedures\n\nExclusion Criteria:\n\n* Previous biopsy showing evidence of breast cancer\n* Have a predisposition to or prior history of thromboembolism, deep venous thrombosis, pulmonary embolism, or stroke\n* History of renal or liver disease\n* Prior ovarian or endometrial cancer\n* Stopped or started hormone replacement within 8 weeks\n* Any other condition or intercurrent illness that in the opinion of the investigator makes the woman a poor candidate for RPFNA\n* Currently taking or have taken specific medications in the past 6 months\n* Participation on any chemoprevention trial within 6 months\n* Current illness which would make potential participant unsuitable for enrollment",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT"
}